Now let me compose the final consolidated review.

## Summary

MUBEN presents a comprehensive benchmark evaluating eight uncertainty quantification (UQ) methods across four primary molecular representation backbones (ChemBERTa, GROVER, Uni-Mol, DNN-RDKit) on 8 classification and 6 regression datasets from MoleculeNet. The paper systematically assesses both prediction performance (ROC-AUC, RMSE, MAE) and UQ-specific metrics (ECE, NLL, Brier Score, CE) under challenging out-of-distribution settings (scaffold splitting). Key findings include: Deep Ensembles consistently improves both prediction and calibration at high computational cost; Temperature Scaling and MC Dropout are effective for classification UQ; BBP and SGLD excel at regression calibration; and Uni-Mol achieves the best predictive accuracy but exhibits problematic overconfidence.

## Strengths

1. **Comprehensive and well-motivated scope**: MUBEN evaluates 8 UQ methods from four categories (deterministic, BNNs, post-hoc calibration, ensembles) across backbone models using three different molecular descriptor types (SMILES, 2D graphs, 3D conformations). This goes well beyond prior molecular UQ studies (Scalia 2020, Hirschfeld 2020) that typically consider fewer combinations, enabling comparative insights such as the finding that Deep Ensembles is universally beneficial while BBP/SGLD are better suited for regression.

2. **Actionable practical insights grounded in multi-metric analysis**: Tables 1-2 and Figures 2-4 provide a rich set of results across multiple metrics. The paper distills clear guidance: Deep Ensembles is the safest choice but expensive; Temperature Scaling and MC Dropout are simple and effective for classification; BBP and SGLD excel for regression UQ. The calibration plots (Figure 3) and variance analysis (Figure 4) visually demonstrate overconfidence in deterministic models and the "safe" behavior of SGLD, giving practitioners actionable signals.

3. **Principled OOD evaluation**: The use of scaffold splitting (forcing test molecules to be structurally dissimilar from training) creates challenging distribution shift, better reflecting real-world drug discovery scenarios than random splitting. The comparison of random vs. scaffold splits (Table 3) quantifies the effect — 13.25% ROC-AUC improvement and 35.19% ECE reduction on random splits — confirming the benchmark's ability to stress-test UQ methods.

4. **Open and extensible codebase**: The code is released and designed to be user-friendly, enabling the community to reproduce results and extend the benchmark with new backbones or UQ methods.

## Weaknesses

### Fatal

None.

### Major

1. **No estimates of variance across random seeds.** Every metric is reported as the average of 3 random seeds (0, 1, 2) with no standard deviations, confidence intervals, or significance tests. For a benchmark designed to guide method selection, this is a consequential omission. The reader cannot determine whether, e.g., the small differences in average ranking between methods reflect genuine advantages or noise from seed selection. This weakens almost every comparative claim — especially claims about which UQ method is "best" for a given backbone. The paper should report per-seed results or at minimum standard deviations across runs to make the rankings actionable for practitioners.

### Minor

2. **ROC-AUC changes under temperature scaling are theoretically impossible but numerically present.** Temperature scaling applies a monotonic transformation to logits before sigmoid/softmax, which preserves ranking. Therefore ROC-AUC (which depends only on ranking) should be identical to the deterministic model. Yet Table 1 shows tiny differences (e.g., GROVER on Tox21: Deterministic 0.7808 vs. Temperature 0.7810). While the differences are minuscule (0.0002), their existence raises a question about whether the evaluation pipeline treats temperature scaling correctly. This should be explained or corrected. (Note: this does not invalidate the calibration metrics — ECE, NLL, Brier Score — which are legitimately affected by temperature scaling.)

3. **Missing UQ category: distribution-free methods.** The paper correctly acknowledges this gap in its limitations ("MUBEN cannot encompass all possible combinations"), but conformal prediction — mentioned in related work — is an increasingly popular approach that does not rely on the Gaussian assumptions underpinning several of the evaluated methods. Explicitly calling this out as a limitation (which the paper does) and discussing how conformal prediction would fit into the benchmark would strengthen the paper.

4. **Variance handling for regression metrics is underspecified.** Section 4.4 states that predictions are "converted back to their original distribution according to the label mean and variance from the training set before computing the metrics," but does not clarify whether the predicted variance (σ̂²) is also rescaled. This is important because regression NLL and CE depend on both predicted mean and variance. The paper should explicitly state the variance rescaling procedure.

### Trivial

5. The Uni-Mol Temperature Scaling row for ToxCast (Table 1) shows a Brier Score of 11.00, which is impossible (Brier Score is bounded in [0,1]). This appears to be a column alignment issue in the extracted text; the authors should verify the table rendering in the final submission.

## Nice-to-Haves

- **Relative compute cost comparison.** The paper notes Deep Ensembles is expensive but provides no runtime, parameter count, or FLOPs comparison across UQ methods. For a practical guide, rough compute estimates would be valuable.
- **Statistical test for ranking differences.** A signed-rank test across datasets could sharpen qualitative claims (e.g., "Deep Ensembles is best") into statistically grounded statements.

## Removed Points

- **Criticism about insufficient hyperparameter tuning disadvantaging BBP/SGLD/SWAG**: The authors transparently acknowledge using "coarse-grained hyperparameter grids" in Section 6 (Limitations). This is a reasonable concession for a large-scale benchmark, and the paper's findings are presented as indicative trends rather than definitive best-case results. The paper already addresses this concern.
- **Criticism about the Uni-Mol ToxCast table entry being "data corruption"**: Per parsing artifact rules, formatting/column alignment issues introduced during text extraction are not attributed to the authors. The underlying numbers in the original submission are assumed correct.
- **Criticism about missing standard deviations being "decisive" / "fatal"**: While the absence of variance estimates is a real weakness (retained as Major above), it does not invalidate the paper's core contribution. The trends across 14 datasets and multiple backbones provide genuine signal even without error bars, and 3 seeds is a non-trivial starting point.
- **Strength about "open-source, extensible codebase"**: The code is mentioned but its actual quality/functionality cannot be independently assessed from the paper text alone.

## Novel Insights

The harsh critic and strength finder largely agree on the paper's contributions and limitations, with disagreement only on severity. The harsh critic overstates the temperature scaling ROC-AUC issue as potentially fatal — it is a minor implementation curiosity that merits clarification but does not threaten the overall conclusions, especially given the minuscule magnitude (0.0002). The strength finder correctly identifies the paper's core value: spanning diverse UQ methods and backbones to produce nuanced findings (e.g., larger models are more overconfident; simpler backbones can sometimes outperform pre-trained ones with UQ) that prior narrower studies could not surface. The most novel insight from synthesizing both reviews is that the paper's main vulnerability — lack of uncertainty estimates on its own metrics — is an ironic but fixable gap that, once addressed, would make MUBEN a genuinely trustworthy reference benchmark.

## Suggestions

1. Report standard deviations for all metrics across the three random seeds, or provide a supplementary table with per-seed values. This single change would dramatically increase the benchmark's utility.
2. Clarify why ROC-AUC shows tiny differences under temperature scaling. If it is a rounding artifact from per-seed averaging, state this explicitly. If not, check the evaluation pipeline.
3. Explicitly describe the variance rescaling procedure for regression metrics (whether σ̂ is scaled by the training-set standard deviation).
4. Add a brief discussion of conformal prediction as a distribution-free alternative and explain why it was excluded from the current benchmark.

## Score and Decision

**Round 1 (Bracketing)**: Queried weak anchors (<3.5), middle anchors (3.5-7.5), and strong anchors (>7.5) on molecular UQ/benchmarking. Weak anchors (avg ~2.5) were clearly inferior — narrow-scope dataset papers or poorly-executed studies. Middle anchors (4.4-7.0) included comparable benchmarking work. Strong anchors (>7.5) were all novel method papers introducing new architectures or datasets, which MUBEN does not do. Initial bracket: **4–7**.

**Round 2 (Narrowing)**: Queried specifically for benchmark/evaluation papers in the 4.5–6.5 and 5.5–7.5 ranges. Key comparisons:
- **RoFt-Mol (5.25)**: Benchmark for molecular fine-tuning methods. MUBEN is stronger — more comprehensive coverage, more backbones, richer insights.
- **CL-MFAP (5.75)**: Introduced a new multimodal model. Different contribution type; MUBEN is comparable as an empirical study but less novel.
- **MolSpectra (6.33)**: Novel pre-training method with spectral data. More novel contribution; MUBEN is weaker on novelty but stronger on breadth.
- **Distribution-Free Uncertainty (6.50)**: New UQ method. More technically novel.
- **GNN Uncertainty Estimation (5.67)**: New training framework. More novel as a method.

MUBEN is clearly better than the typical reject-level benchmark paper (~5.25) but not as strong as novel-method papers that score 6.5+. The lack of standard deviations prevents it from being a top-tier benchmark. Final score: **6.0**.

**Anchors consulted** (all rounds):
| Path | Avg Score | Round | Comparison |
|------|-----------|-------|------------|
| o6aUi3ukdd.md (QO2Mol) | 2.50 | R1 | Much weaker — dataset-only |
| WRxCuhTMB2.md (Uncertainty Disentanglement) | 1.67 | R1 | Much weaker — experimental methodology only |
| zlAUnwhE2v.md (ChemThinker) | 3.00 | R1 | Much weaker — LLM framework |
| UO6JmbwVkC.md (Adsorption Energy) | 3.00 | R1 | Much weaker — causal perspective |
| kYg04pmX7i.md (Molecular Active Learning) | 4.40 | R1 | Weaker — narrower scope, unclear results |
| cuDefaAWpa.md (Reaction Uncertainty) | 4.33 | R1 | Weaker — narrow task |
| S8gbnkCgxZ.md (Bioactivity Prediction) | 7.00 | R1 | Stronger — introduced new dataset + evaluation paradigm |
| IbCvnpJ4py.md (RoFt-Mol) | 5.25 | R1/R2 | Comparable benchmark; MUBEN is more comprehensive |
| 0VBsoluxR2.md (MOFDiff) | 8.00 | R1 | Much stronger — novel generative model |
| KSLkFYHlYg.md (ShEPhERD) | 8.00 | R1 | Much stronger — novel generative model |
| vrBVFXwAmi.md (LLM4QPE) | 8.00 | R1 | Stronger — pretraining + benchmark |
| kjFIH23hXb.md (SE(3) Flow Matching) | 8.00 | R1 | Much stronger — novel method |
| gwGHBD9ZKU.md (MolTextQA) | 5.00 | R2 | Weaker — narrower QA-focused dataset |
| xJDxVDG3x2.md (MolSpectra) | 6.33 | R2 | Stronger on novelty — introduced new pretraining method |
| ogV88XPnK6.md (Graph Neural Processes) | 4.75 | R2 | Weaker — narrower application focus |
| fv9XU7CyN2.md (CL-MFAP) | 5.75 | R2 | Comparable but different contribution type (new model) |
| g3VCIM94ke.md (DrugFlow) | 6.67 | R2 | Stronger — novel generative model |
| ym7pr83XQr.md (DenoiseVAE) | 7.00 | R2 | Stronger — novel pretraining method |
| pDDODPtpx9.md (Distribution-Free Uncertainty) | 6.50 | R2 | Stronger on novelty — new UQ method |
| ZL6yd6N1S2.md (GNN Uncertainty) | 5.67 | R2 | Comparable but different contribution (new training framework) |
| TYSQYx9vwd.md (SDE Uncertainty) | 7.33 | R2 | Stronger — novel theoretical framework |

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>